Apogee Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VR ADVISER, LLC | 11/14/2025 | 8.49 M | $337.44 M | 0.00% | 14.54% |
| FMR LLC | 11/13/2025 | 6.92 M | $274.79 M | 0.14% | 11.84% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 4.72 M | $187.67 M | 24.12% | 8.08% |
| RTW INVESTMENTS, LP | 11/14/2025 | 2.71 M | $107.75 M | 0.00% | 4.64% |
| BLACKROCK, INC. | 11/12/2025 | 2.69 M | $106.72 M | 4.82% | 4.60% |
| VANGUARD GROUP INC | 11/07/2025 | 2.25 M | $89.22 M | 6.48% | 3.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 2.16 M | $85.76 M | -6.59% | 3.69% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2025 | 2.05 M | $81.39 M | 0.00% | 3.51% |
| STATE STREET CORP | 11/14/2025 | 1.66 M | $65.77 M | 31.47% | 2.83% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 1.52 M | $60.46 M | 58.74% | 2.60% |
| BRAIDWELL LP | 11/14/2025 | 1.44 M | $57.16 M | -2.69% | 2.46% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 1.42 M | $56.38 M | 2.23% | 2.43% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 1.35 M | $53.71 M | 14.37% | 2.31% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 1.17 M | $46.62 M | 69.60% | 2.01% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.17 M | $46.45 M | 135.90% | 2.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1.14 M | $45.20 M | 1.08% | 1.95% |
| MERCER GLOBAL ADVISORS INC /ADV | 11/14/2025 | 970.58 K | $38.56 M | 18.31% | 1.66% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 892.20 K | $35.45 M | 14.00% | 1.53% |
| UBS GROUP AG | 11/13/2025 | 799.47 K | $31.76 M | 646.07% | 1.37% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 750.53 K | $29.82 M | -1.36% | 1.28% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 730.76 K | $29.03 M | -14.28% | 1.25% |
| BARCLAYS PLC | 11/12/2025 | 642.32 K | $25.52 M | 5.50% | 1.10% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 599.62 K | $23.82 M | -9.04% | 1.03% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 568.08 K | $22.57 M | -11.56% | 0.97% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 565.42 K | $22.46 M | 642.21% | 0.97% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 524.09 K | $20.82 M | 5.88% | 0.90% |
| NOVO HOLDINGS A/S | 11/14/2025 | 500.00 K | $19.87 M | 11.26% | 0.86% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 485.98 K | $19.31 M | -4.58% | 0.83% |
| MORGAN STANLEY | 11/14/2025 | 464.96 K | $18.47 M | -2.05% | 0.80% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 430.46 K | $17.10 M | 75.60% | 0.74% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 425.00 K | $16.89 M | 100.00% | 0.73% |
| FIRST TURN MANAGEMENT, LLC | 11/14/2025 | 402.81 K | $16.00 M | 29.32% | 0.69% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 393.91 K | $15.65 M | -22.61% | 0.67% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 11/14/2025 | 374.41 K | $14.88 M | 21.14% | 0.64% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 363.26 K | $14.43 M | 100.00% | 0.62% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 319.90 K | $12.71 M | 20.09% | 0.55% |
| GREAT POINT PARTNERS LLC | 11/14/2025 | 304.00 K | $12.08 M | 100.00% | 0.52% |
| COMMODORE CAPITAL LP | 11/14/2025 | 290.00 K | $11.52 M | 0.00% | 0.50% |
| NORTHERN TRUST CORP | 11/14/2025 | 284.48 K | $11.30 M | 7.68% | 0.49% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 235.00 K | $9.34 M | -81.79% | 0.40% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 217.21 K | $8.63 M | -14.74% | 0.37% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 215.85 K | $8.60 M | 81.01% | 0.37% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 200.00 K | $7.95 M | 0.00% | 0.34% |
| BLACKSTONE INC. | 11/14/2025 | 190.35 K | $7.56 M | 6.61% | 0.33% |
| SG AMERICAS SECURITIES, LLC | 10/23/2025 | 134.23 K | $5.33 M | 100.00% | 0.23% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 132.40 K | $5.26 M | 0.96% | 0.23% |
| UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 10/30/2025 | 131.44 K | $5.22 M | 4.46% | 0.23% |
| CAPITAL WORLD INVESTORS | 11/13/2025 | 127.62 K | $5.07 M | -34.18% | 0.22% |
| DIADEMA PARTNERS LP | 11/14/2025 | 127.40 K | $5.06 M | -18.49% | 0.22% |
| CANDRIAM S.C.A. | 11/06/2025 | 126.08 K | $5.01 M | 100.00% | 0.22% |
Apogee Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 214 institutional investors and hedge funds held shares of Apogee Therapeutics, Inc.. The most heavily invested institutionals were:
VR Adviser, LLC: 8.49 M
FMR LLC: 6.92 M
WELLINGTON MANAGEMENT GROUP LLP: 4.72 M
RTW INVESTMENTS, LP: 2.71 M
BlackRock, Inc.: 2.69 M
VANGUARD GROUP INC: 2.25 M
101.98% of Apogee Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 63.31 M shares in the last 24 months. This purchase volume represents approximately $4.78 B in transactions.